Lamictal (lamotrigine) stabilizes mood in bipolar disorder primarily by calming overactive neurons in the brain. It does this by blocking sodium channels on nerve cells and reducing the release of glutamate, an excitatory brain chemical linked to mood instability. Unlike many bipolar medications that target mania, lamotrigine’s strongest benefit is preventing depressive episodes, which makes it unusual among mood stabilizers.
How It Works at the Brain Level
Neurons communicate by firing electrical signals, and sodium channels are the gates that allow those signals to travel. Lamotrigine physically lodges itself inside the inner pore of these sodium channels, blocking the flow of sodium ions and preventing neurons from firing too rapidly or erratically. Think of it as a speed limiter on nerve cells that are prone to racing out of control.
This sodium channel blockade has a downstream effect that matters even more for mood: it reduces the release of glutamate and aspartate, two brain chemicals that ramp up neural excitability. Multiple studies have confirmed that lamotrigine treatment leads to measurably lower glutamate levels in brain tissue and the fluid between neurons. Since excessive glutamate signaling is associated with both mood instability and the depressive phase of bipolar disorder, this reduction is likely central to lamotrigine’s mood-stabilizing and antidepressant-like effects. Lithium, interestingly, shares this glutamate-lowering property.
Lamotrigine also reduces certain calcium currents in neurons, which further dampens the chain reaction of overexcitation. Together, these mechanisms don’t sedate you or flatten your emotions the way some mood stabilizers can. Instead, they quiet the neural overactivity that drives mood episodes while leaving normal brain function largely intact.
Stronger Against Depression Than Mania
Lamotrigine is FDA-approved as a maintenance treatment for bipolar disorder, meaning it’s used long-term to prevent future episodes rather than to treat an active crisis. Its standout strength is protecting against depressive episodes. In clinical data, lamotrigine delayed the return of major depressive episodes to a similar degree in both bipolar I and bipolar II patients, with the time to relapse reaching roughly 234 days for bipolar I and 295 days for bipolar II (measured at the 25th percentile).
For overall mood episode prevention, lamotrigine performed significantly better in bipolar II than bipolar I. Patients with bipolar II went about 183 days before any mood episode recurred, compared to 71 days for bipolar I. The difference was especially pronounced for hypomania and mania prevention: in bipolar II, the drug delayed hypomanic episodes so effectively that a relapse timepoint couldn’t even be calculated in the study, while bipolar I patients experienced mania-related recurrence at around 105 days.
This profile means lamotrigine is often a first-line choice for bipolar II, where depression dominates the illness. For bipolar I, where full manic episodes are a concern, it’s frequently paired with another medication that provides stronger anti-manic coverage.
Why the Dose Increases So Slowly
If you’ve been prescribed lamotrigine, the slow startup is one of the first things you’ll notice. The standard schedule begins at just 25 mg per day (or 25 mg every other day if you’re also taking valproate) and increases in two-week steps over six to seven weeks before reaching the target dose, typically 200 mg daily.
This pace exists for a specific safety reason: lamotrigine carries a small but real risk of a severe skin reaction called Stevens-Johnson syndrome (SJS), a potentially life-threatening condition where the skin and mucous membranes blister and peel. In adult clinical trials, possible SJS occurred in about 0.1% of patients. A large observational study found the overall risk of serious rash at roughly 0.26%, or about 1 in 400. The risk is higher in children under 16, at around 0.5%.
Three factors are known to increase this risk: taking valproate at the same time, starting at too high a dose, and increasing the dose too quickly. The slow titration schedule directly addresses the last two. Starter kits are available that pre-package the correct pills for each phase to help you stay on track. Skipping ahead or doubling up because you’re eager to reach a therapeutic dose is genuinely dangerous.
What Valproate Does to Your Dose
If you take valproate (Depakote) alongside lamotrigine, the interaction is significant enough to change your entire dosing schedule. Valproate cuts lamotrigine’s clearance from your body by approximately 50%, meaning the drug builds up to roughly double the concentration it would otherwise reach. That’s why the titration schedule for patients on valproate starts at half the usual dose (25 mg every other day instead of daily) and tops out at 100 mg rather than 200 mg.
This interaction also works in reverse. If valproate is added to an existing lamotrigine regimen, the lamotrigine dose needs to be reduced by half immediately to avoid a sudden spike in blood levels. Conversely, if valproate is stopped, lamotrigine levels will drop and the dose may need to increase.
Birth Control Can Lower Blood Levels
Estrogen-containing oral contraceptives interact with lamotrigine in a way that catches many patients off guard. Certain progestins in combination birth control pills, particularly drospirenone and levonorgestrel, can significantly reduce lamotrigine concentrations in the blood. Studies have found measurable differences in drug levels between the active pill phase and the placebo pill week of a birth control pack.
This means your lamotrigine levels may fluctuate throughout your menstrual cycle if you’re on hormonal contraception, potentially dropping low enough to reduce its protective effect during the weeks you’re taking active pills and then rebounding during the pill-free interval. Not all progestins cause this issue equally. Formulations containing gestoden did not appear to significantly affect lamotrigine levels. If you use hormonal birth control and take lamotrigine, your prescriber may need to adjust your dose or consider an alternative contraceptive method.
How Long Until It Works
Because of the slow titration, you won’t reach a full therapeutic dose for at least five to seven weeks. After that, it takes additional time for blood levels to stabilize. Pharmacokinetic data shows that reaching a true steady state can take anywhere from four to eight weeks after a dose change, and longer if other medications are being adjusted at the same time. Realistically, you’re looking at roughly two to three months from first pill to full effect.
Blood levels between 3 and 15 mcg/mL are considered the therapeutic range for most patients, though there’s wide individual variation. Some people tolerate and respond well at levels others would find too high or too low. Signs of toxicity generally appear when peak levels exceed 20 mcg/mL, though some individuals tolerate concentrations several times higher. Blood monitoring isn’t always routine, but it can be useful if your response seems inconsistent or if you’re taking interacting medications.
The patience required during the startup period is one of lamotrigine’s genuine drawbacks. But for many people with bipolar disorder, especially those whose illness is dominated by depression, the long-term payoff of fewer and less severe depressive episodes makes the slow ramp-up worthwhile.